ESR1 and COVID-19: Other studies have reported an elevation in acute-phase reactants among patients with COVID-19, including ESR, C-reactive protein (CRP), serum amyloid A, and ferritin—suggesting a rapid activation of the innate immune response (Jamilloux et al., 2020).